Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GRNA | Common Stock | Award | +5.74M | 5.74M | Feb 2, 2022 | by MLS Capital Fund II, L.P. | F1, F2 | |||
transaction | GRNA | Common Stock | Purchase | $750K | +75K | +1.31% | $10.00* | 5.82M | Feb 2, 2022 | by MLS Capital Fund II, L.P. | F2, F3 |
Id | Content |
---|---|
F1 | Issued pursuant to the terms of a business combination agreement involving the issuer and GreenLight Biosciences, Inc. in exchange for capital stock previously issued by such company. |
F2 | Mr. Kishore, a director of the Issuer, is the Manager of MLS Capital fund II, L.P. and has the power to vote, or to direct the voting of, the shares held by MLS Capital fund II, L.P. By virtue of the foregoing, Mr. Kishore may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the shares held by MLS Capital fund II, L.P. Mr. Kishore disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein. |
F3 | Amount consists of 75,000 shares of common stock issued pursuant to a subscription agreement entered into between the Issuer and MLS Capital fund II, L.P. |